Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients

Purpose Lung cancer (LC) is the most common source of brain metastases (BM). Because of the difficulty in predicting LC patients who will develop BM, we aimed to identify the clinical and serologic markers that could predict the presence of BM in LC patients.